KKR Group Finance Co. IX LLC 4.625% Subordinated Notes due 2061 (KKRS) is trading at $16.13 as of 2026-04-01, posting a single-session gain of 0.81% in recent trading. As a long-duration subordinated note listed on public markets, KKRS exhibits price sensitivity to both broader fixed income market trends and discrete technical price levels that have emerged in recent weeks. No recent earnings data is available for KKRS, as the instrument operates with pre-defined coupon terms and does not releas
KKRS Stock Analysis: KKR 4.625% 2061 Subordinated Notes rise 0.81 percent to 16.13
KKRS - Stock Analysis
3050 Comments
1310 Likes
1
Malaila
Active Contributor
2 hours ago
This feels like a decision I didnβt make.
π 250
Reply
2
Asasha
Expert Member
5 hours ago
Free US stock alerts and analysis providing investors with real-time opportunities, expert strategies, and reliable insights for steady portfolio growth and risk management. Our alert system ensures you never miss important market movements that could impact your investment performance. We deliver curated picks, technical analysis, and risk management tools to support your investment strategy. Join our community of informed investors achieving consistent returns through our comprehensive platform and expert guidance.
π 276
Reply
3
Guyann
Consistent User
1 day ago
Market breadth shows divergence, highlighting selective strength in certain sectors.
π 204
Reply
4
Kahlei
Active Contributor
1 day ago
Indices continue to test critical support and resistance levels, guiding short-term trading decisions.
π 36
Reply
5
Johnan
Community Member
2 days ago
Expert US stock balance sheet health analysis and debt sustainability metrics to assess financial stability and long-term risk for portfolio companies. Our fundamental analysis digs deep into financial statements to identify hidden risks that might not be obvious from headline numbers alone. We provide debt analysis, liquidity metrics, and solvency indicators for comprehensive financial health assessment. Understand balance sheet health with our comprehensive fundamental analysis and risk metrics for safer investing.
π 282
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.